Noroseal
Active substance
ATC code
Species
Cattle (dairy cows)
Indications
Prevention of new intramammary infections throughout the dry period.
In cows considered likely to be free of sub-clinical mastitis, the product may be suitable for use on its own in dry cow management for mastitis control.
Selection of cows for treatment with the product should be based on veterinary clinical judgement. Selection criteria may be based on the mastitis and cell count history of individual cows, or recognised tests for the detection of subclinical mastitis such as bacteriological sampling.
Dose to be administered and administration route
Intramammary use.
Infuse the content of one syringe of the product into each udder quarter immediately after the last milking of the lactation (at drying off). Do not massage the teat or udder after infusion of the product.
Care must be taken not to introduce pathogens into the teat in order to reduce the risk of post-infusion mastitis (aseptic technique).
It is essential that the teat is thoroughly cleaned and disinfected, with surgical spirit or alcohol-impregnated wipes. The teats should be wiped until the wipes are no longer visibly dirty. Teats should be allowed to dry prior to infusion. Infuse aseptically and avoid contamination of the syringe nozzle. Following infusion it is advisable to use an appropriate teat dip or spray.
Under cold conditions the product may be warmed to room temperature in a warm environment to aid syringeability.
Adverse reactions
Acute mastitis has been reported very rarely after use of this product, primarily due to the poor infusion technique and lack of hygiene. Please refer to sections 4.5 and 4.9 regarding the importance of aseptic technique.
The frequency for adverse reactions is defined using the following convention:
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | |
EAN | 5023534019268 |